The Trump administration struck deals with pharmaceutical companies Novo Nordisk and Eli Lilly to lower prices and copays for ...

Meitheal Pharmaceuticals has gotten federal approval for a new kind of antibiotic for use on hospitalized patients with ...

Known as pre-methylenomycin C lactone, this antibiotic is derived from a model species that’s been studied for nearly 80 ...

A Trump administration deal to cut prices for popular weight-loss drugs like Wegovy and Zepbound will allow millions more ...

Helen Zgurskaya and Valentin Rybenkov, researchers at the University of Oklahoma, are leading a five-year, $5.3 million project funded by the National Institute of Allergy and Infectious Diseases to ...

Learn how chemists were studying a known antibiotic when they discovered a molecule 100 times more potent at defeating ...

Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have ...

Novo Nordisk and Eli Lilly said they've agreed to sell their blockbuster drugs Wegovy and Zepbound at a discount.

Eli Lilly and Novo Nordisk officials have agreed to lower the cost of GLP-1 obesity drugs for Medicaid and Medicare ...

The bacteria Acinetobacter baumannii (A. baumannii) is a haunting presence in many hospitals in the United States, where more ...

WASHINGTON (AP) — President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand ...

Vertex Pharmaceuticals reported on Monday that it beat Wall Street estimates for third-quarter results, driven by strong demand for its cystic fibrosis treatments and early contributions from newer ...